0Studies tracked
0Claims cite
0Videos use
Average study score: 52/100
Bibliography
Studies by this author
1 study attributed to Keith Egan on the platform. Click a card to read the full analysis.
Study
Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemcitabine and NAB-paclitaxel therapy in advanced pancreatic cancer
To evaluate safety, tolerability, and efficacy of oral paricalcitol plus gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic ductal adenocarcinoma (PDAC).